Osteoarthritis
📧 Sign up to get email alerts when something new happens for Osteoarthritis.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2021-07-13Clinical Trial Update: Randomized, Double-Blind, Placebo-Controlled, Phase 2 Study In Subjects With Osteoarthritic Pain Of The Knee [Phase 2]
A Phase 2 randomized, double-blind, placebo-controlled trial in osteoarthritic knee pain has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-06-30Clinical Trial Update: Evaluate the Efficacy and Safety of Fasinumab in Patients With Moderate-to-Severe Chronic Low Back Pain and Osteoarthritis of the Hip or Knee [Phase 3]
Phase 3 trial evaluating fasinumab for chronic low back pain and osteoarthritis; terminated with posted results.
-
CLINICAL_TRIALS trial_result · 2021-06-25Clinical Trial Update: Protocol to Monitor the Neurological Development of Infants With Exposure in Utero From Birth to 15 Months in Tanezumab Clinical Studies [Phase 3]
A Phase 3 protocol update describes monitoring neurological development in infants exposed to tanezumab in utero from birth to 15 months in …
-
CLINICAL_TRIALS trial_result · 2021-06-24Clinical Trial Update: Long-Term Analgesic Efficacy And Safety Of Tanezumab Alone Or In Combination With Non-Steroidal Anti-Inflammatory Drugs (NSAIDs) Versus NSAIDs Alone In Patients With Osteoarthritis Of The Knee Or Hip [Phase 3]
Phase 3 trial update on long-term analgesic efficacy and safety of tanezumab alone or with NSAIDs versus NSAIDs alone in knee or hip osteoar…
-
CLINICAL_TRIALS trial_result · 2021-06-16Clinical Trial Update: Study Comparing a Generic Diclofenac Sodium Topical Gel, 1% to Voltaren in the Treatment of Subjects With Osteoarthritis of the Knee [Phase 3]
Phase 3 trial comparing a generic diclofenac sodium topical gel 1% to Voltaren in knee osteoarthritis has completed with results posted.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2021-05-21Clinical Trial Update: Mobile Motivational Physical Activity Targeted Intervention [NA]
A completed clinical trial evaluating a mobile motivational physical activity intervention for osteoarthritis; results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-05-17Clinical Trial Update: Tanezumab in Osteoarthritis of the Hip or Knee (2) [Phase 3]
Phase 3 clinical trial update for tanezumab in osteoarthritis of the hip or knee; study completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-17Clinical Trial Update: A Study Evaluating the Safety, Pharmacokinetics, and Pharmacodynamics of KA34 in Subjects With Knee Osteoarthritis [Phase 1]
Phase 1 trial evaluating KA34 in knee osteoarthritis has completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-14Clinical Trial Update: Tanezumab In Osteoarthritis Of The Hip Or Knee [Phase 3]
Phase 3 clinical trial update for tanezumab in osteoarthritis of the hip or knee has been terminated; results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-13Clinical Trial Update: Tanezumab In Osteoarthritis Of The Knee (2) [Phase 3]
Phase 3 trial results for tanezumab in knee osteoarthritis have been completed with results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-13Clinical Trial Update: Compare the Effect of Eupatilin and Rebamipide on the Prevention of Gastroenteropathy [Phase 4]
Phase 4 clinical trial comparing eupatilin and rebamipide for prevention of gastroenteropathy, sponsored by Seoul National University Borama…
-
CLINICAL_TRIALS trial_result · 2021-05-12Clinical Trial Update: A Study to Assess Efficacy and Safety of GLPG1972/S201086 in Participants With Knee Osteoarthritis [Phase 2]
Phase 2 trial updating the efficacy and safety of GLPG1972/S201086 in knee osteoarthritis has completed with posted results.
-
CLINICAL_TRIALS trial_result · 2021-05-11Clinical Trial Update: Clinical Trial of YYC301 for Treatment of Osteoarthritis of the Knee [Phase 2]
Phase 2 clinical trial update for YYC301 in knee osteoarthritis has completed.
-
CLINICAL_TRIALS trial_result · 2021-05-10Clinical Trial Update: Extension Study Of Tanezumab In Osteoarthritis [Phase 3]
Extension study results for tanezumab in osteoarthritis were reported; the study was terminated.
-
CLINICAL_TRIALS trial_result · 2021-05-05Clinical Trial Update: Efficacy And Safety Study Of Tanezumab Subcutaneous Administration In Osteoarthritis - A Subcutaneous/Intravenous Bridging Study [Phase 3]
A Phase 3 bridging study evaluating tanezumab given subcutaneously versus intravenous in osteoarthritis shows terminated status with posted …
-
FDA approval · 2021-04-30FDA Approved: SULINDAC — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
The FDA approved a supplemental application for sulindac from Sun Pharmaceutical Industries, Inc., authorizing changes to its labeling and/o…
-
FDA approval · 2021-04-29FDA Approved: ETODOLAC — Supplemental Application (Apotex Corp.)
FDA approved a supplemental application for Etodolac (Apotex Corp.), approving a generic version of etodolac under an ANDA.
-
FDA approval · 2021-04-29FDA Approved: NABUMETONE — Supplemental Application (Chartwell RX, LLC)
FDA approves a supplemental application for nabumetone submitted by Chartwell RX, LLC. Nabumetone is an NSAID used for pain relief in condit…
-
FDA approval · 2021-04-28FDA Approved: TOLMETIN SODIUM — Supplemental Application (Atland Pharmaceuticals, LLC)
The FDA approved a supplemental application for tolmetin sodium submitted by Atland Pharmaceuticals, LLC, resulting in updated labeling for …
-
FDA approval · 2021-04-28FDA Approved: INDOCIN — Supplemental Application (Zyla Life Sciences US LLC)
The FDA has approved a supplemental application for INDOCIN (indomethacin) by Zyla Life Sciences US LLC.
-
FDA approval · 2021-04-28FDA Approved: NAPROXEN — Supplemental Application (Acella Pharmaceuticals, LLC)
The FDA approved a supplemental application for Naproxen filed by Acella Pharmaceuticals, LLC, updating the product's approval status.
-
FDA approval · 2021-04-28FDA Approved: NABUMETONE — Supplemental Application (ScieGen Pharmaceuticals Inc)
FDA approved a supplemental application for Nabumetone from ScieGen Pharmaceuticals Inc, resulting in updated labeling and potential new ind…
-
FDA approval · 2021-04-28FDA Approved: INDOMETHACIN — Supplemental Application (Amneal Pharmaceuticals LLC)
FDA approved Amneal Pharmaceuticals LLC's supplemental application for Indomethacin, approving a generic Indomethacin product.
-
FDA approval · 2021-04-28FDA Approved: NABUMETONE — Supplemental Application (Lupin Pharmaceuticals, Inc.)
FDA approved Lupin Pharmaceuticals' supplemental application for Nabumetone.
-
FDA approval · 2021-04-28FDA Approved: INDOMETHACIN — Supplemental Application (XLCare Pharmaceuticals Inc.)
FDA approved a supplemental application for Indomethacin from XLCare Pharmaceuticals Inc. This approval updates the drug's existing FDA appr…